Medical/Pharmaceuticals
4G Clinical Announces Appointment of Life Science Service and Tech Leader Dr. Ronan Brown as New Chief Operating Officer
Brown brings years of industry expertise to oversee and maximize 4G Clinical's operational efficiency and excellence. WELLESLEY, Mass., Aug. 16, 2024 /PRNewswire/ -- 4G Clinical, a global leader in randomization and trial supply management (RTSM) and supply forecasting optimization software for ...
Cresilon Receives FDA Clearance for TRAUMAGEL
Hemostatic gel designed to control moderate to severe bleeding in seconds and save lives NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn -based biotechnology company focused on hemostatic medical device technologies, today announced it has received U.S. Food and Dru...
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
Gross margin increased to 79.5%; product pipeline continues to advance Company anticipates double-digit year-over-year revenue growth and bottom line breakeven for Fiscal Year 2025 GAITHERSBURG, Md., Aug. 15, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma"...
Fractal Launches vaidya.ai, a Multimodal Health Assistant
NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Fractal (www.fractal.ai
AI + medical care|Neusoft Education launches the Healthcare Training Lab to support practical teaching for software-related majors in universities
HONG KONG, Aug. 15, 2024 /PRNewswire/ -- With the trend of population aging in China, the government and all sectors of society are taking active measures to address the challenges of the digital age. Following the rise of the "silver economy", the smart elderly care industry will be promising, a...
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT
HELSINKI, Aug. 15, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it is to enter into a pre-clinical development agreement with the Plasma-derived Therapies Business Unit of Takeda Pharmaceuticals, Inc., the R&D-driven biop...
NSG BioLabs and Merck Collaborates to Support Biotech Start-ups to Advance Research & Innovations
* The collaboration focuses on offering guidance, mentorship, and access to
expertise to the start-ups housed within NSG Biolabs SINGAPORE, Aug. 15, 2024
/PRNewswire/ --NSG BioLabs
Sisram Medical to Report H1 2024 Financial Results on August 21 and Hold a Conference Call on August 22
H1 2024 conference call to be held on August 22, at 8:30 a.m. Eastern Time HONG KONG, Aug. 15, 2024 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the " Group"), a global consumer wellness group featuring a first-of-it...
REMOVERY TO PROVIDE 150 FREE TATTOO REMOVAL PACKAGES TO COMMEMORATE THE INAUGURAL WORLD TATTOO REMOVAL DAY
On August 14, the world's tattoo removal experts will provide 150 treatments to individuals in need across their global studio locations AUSTIN, Texas, Aug. 14, 2024 /PRNewswire/ -- To bring awareness to the safety, efficacy and accessibility of tattoo removal treatment,Removery is presenting th...
Strategic Partnership Between Beyond Medical Group (Singapore) and SingMed Medical Centre (Cambodia) Enhances Healthcare Collaboration
Beyond Medical Pledges to Join Forces with SingMed to Enhance Access to
Healthcare and Elevate Care Standards Across Both Regions
SINGAPORE, Aug. 14, 2024 /PRNewswire/ -- Beyond Medical Group Singapore
Alfred Health Enhances Cancer Patient Care with Oracle Health
Leading Victorian healthcare network integrates oncology and EHR solutions to deliver more informed care across its locations AUSTIN, Texas and VICTORIA, Australia, Aug. 13, 2024 /PRNewswire/ -- Leading Victorian healthcare network, Alfred Health, has extended its long-standing Oracle Health foo...
Sinch AI Used to Safely Pre-Triage Patients
STOCKHOLM, Aug. 13, 2024 /PRNewswire/ -- Sinch (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communications Cloud, is excited to announce that MINDD, a Dutch medical technology company, has selected Sinch to develop an advanced AI-driven...
Australian biotech incubator Proto Axiom announces $20M Series B first close
$20M unlocked for opportunities in Australian biotech innovation, valuing Proto Axiom at$90M SYDNEY, Aug. 13, 2024 /PRNewswire/ -- Proto Axiom, the Australian biomedical technology incubator has today announced a$20 million first close of its targeted$30 million Series B, to bolster Australia's...
Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months
* Docquity's Awareness to Advocacy (A2A) Program and strong local distribution network enabled SIT's duo probiotic sales to surpass the market growth rate of 15% * The technology platform boosted SIT's HCP education efforts, more than doubling its reach to 2,000 HCPs within six months and aim...
Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE
ROCKVILLE, Md. and SUZHOU, China, Aug. 13, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing both first- and best-in-class therapies for malignancies, announced today it has been cleared by the Ce...
Chang Gung Cancer Proton Therapy Achieves Breakthrough
Research Confirms Effective Control of Large Liver Cancer, Doubling Survival
Time
Published in the International Journal of Radiation Oncology
Biosyngen's BRG01 Receives FDA Approval for Phase II Clinical Trial
SINGAPORE, Aug. 13, 2024 /PRNewswire/ -- Biosyngen is proud to announce that the U.S. Food and Drug Administration (FDA) has approved its BRG01, an EBV-specific CAR-T cell therapy, to proceed with a pivotal Phase lI clinical trial.This marks the first cell therapy to enter Phase lI trials in both...
Pantai Hospital Kuala Lumpur Introduces Outpatient Parenteral Antimicrobial Therapy (OPAT) for Improved Patient Care
KUALA LUMPUR, Malaysia, Aug. 12, 2024 /PRNewswire/ -- Pantai Hospital Kuala
Lumpur (PHKL) has officially introduced its Outpatient Parenteral Antimicrobial
Therapy (OPAT) service, offering an innovative treatment option that enhances
patient care.
AI in the IVF Process is the Standard of Care at Virtus Fertility Centre Singapore
The technology developed by Virtus Health's scientists contributes to IVF medicine by shortening the time to a successful pregnancy and improving overall success rates. SINGAPORE, Aug. 13, 2024 /PRNewswire/ -- Virtus Fertility Centre Singapore (VFCS) announced that artificial intelligence (AI), ...
MediPortal Introduces AI for Practice Management in Australia
PERTH, Australia, Aug. 13, 2024 /PRNewswire/ -- MediPortal PTY LTD. (MediPortal) has launched an AI-powered practice intelligence platform for Australian medical practices, aiming to enhance efficiency and patient care. Developed as the brainchild of a practising general practitioner, this innov...
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1168 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1129 media titles]
2026-11-05 06:52Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00Fintech OPay Raises $304 Million Ahead of NYSE Debut: NYSE Content Update
[Picked up by 1079 media titles]
2026-10-30 22:34H.E. Ahmed Al-Khateeb, Saudi Minister of Tourism, Inaugurates Saudi Land at WTM London 2026, Reinforcing Saudi's Commitment to Global Travel Trade
[Picked up by 1067 media titles]
2026-11-04 07:31